MAYO CLINIC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1889-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mayoclinic.org
Immune Responses in Prostate, Lung, Melanoma and Breast Cancer Patients Following Stereotactic Body Radiotherapy (SBRT), Intensity Modulated Radiotherapy (IMRT) or Brachytherapy
Active, not recruiting
- Conditions
- Breast CancerProstate CancerLung CancerMelanoma
- First Posted Date
- 2013-01-29
- Last Posted Date
- 2025-02-18
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 97
- Registration Number
- NCT01777802
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Mayo Clinic Health Connection Discovery Trial
Not Applicable
Completed
- Conditions
- Surgical Recovery
- Interventions
- Other: Electronic Care plan deliveryOther: Standard care
- First Posted Date
- 2013-01-29
- Last Posted Date
- 2013-01-29
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 250
- Registration Number
- NCT01777841
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Arterial Spin Labeling MRI Focal Abnormalities in Refractory Epilepsy
Not Applicable
Completed
- Conditions
- Focal Epilepsy
- Interventions
- Device: Arterial Spin Labeled (ASL) MRI sequence
- First Posted Date
- 2013-01-21
- Last Posted Date
- 2015-03-06
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 73
- Registration Number
- NCT01772654
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
The PCI Choice Trial: a Pilot Randomized Trial of a Decision Aid for Patients With Stable Coronary Artery Disease
Not Applicable
Completed
- Conditions
- Stable Angina
- Interventions
- Other: Decision Aid
- First Posted Date
- 2013-01-18
- Last Posted Date
- 2023-03-15
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 132
- Registration Number
- NCT01771536
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Kinetics of Troponin and BNP in Breast Cancer Chemotherapy With Adriamycin and Trastuzumab
Completed
- Conditions
- Breast Cancer
- First Posted Date
- 2013-01-18
- Last Posted Date
- 2018-03-23
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 26
- Registration Number
- NCT01771549
- Locations
- 🇺🇸
Mayo Clinic, Jacksonville, Florida, United States
Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer
Phase 2
Completed
- Conditions
- Chromophobe Renal Cell CarcinomaMetastatic Renal Cell CancerPapillary Renal Cell CarcinomaKidney OncocytomaStage IV Renal Cell CancerCarcinoma of the Collecting Ducts of BelliniKidney Medullary CarcinomaRecurrent Renal Cell CarcinomaSarcomatoid Renal Cell Carcinoma
- Interventions
- First Posted Date
- 2013-01-14
- Last Posted Date
- 2025-03-03
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 38
- Registration Number
- NCT01767636
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
🇺🇸Mayo Clinic in Florida, Jacksonville, Florida, United States
🇺🇸Mayo Clinic in Arizona, Scottsdale, Arizona, United States
Effect of Mindful Eating on Body Mass Index in Obese Adolescents
Phase 3
Completed
- Conditions
- Adolescent Obesity
- Interventions
- Behavioral: Standard dietary counsellingBehavioral: Mindful Eating
- First Posted Date
- 2013-01-09
- Last Posted Date
- 2014-01-22
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 21
- Registration Number
- NCT01764113
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Long-Term Outcome Following the Treatment of Pediatric Scoliosis
Not Applicable
Completed
- Conditions
- Adolescent Idiopathic Scoliosis
- Interventions
- Other: Long-term outcomes
- First Posted Date
- 2013-01-04
- Last Posted Date
- 2019-03-19
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 66
- Registration Number
- NCT01760434
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Colchicine and CRP in Atrial Fibrillation and AF Ablation
Phase 2
Completed
- Conditions
- Atrial Fibrillation
- Interventions
- Drug: Colchicine, 0.6 mg PO BIDDrug: Matching placebo
- First Posted Date
- 2012-12-24
- Last Posted Date
- 2019-05-09
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 26
- Registration Number
- NCT01755949
- Locations
- 🇺🇸
Mayo Clinic Florida, Jacksonville, Florida, United States
Effects of Androgen Administration on Inflammation in Normal Women
Not Applicable
Completed
- Conditions
- Hyperandrogenism
- Interventions
- Dietary Supplement: Dehydroepiandrosterone (DHEA)Other: Placebo
- First Posted Date
- 2012-12-20
- Last Posted Date
- 2013-11-18
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 25
- Registration Number
- NCT01753037
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
© Copyright 2025. All Rights Reserved by MedPath